Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-10-12
pubmed:databankReference
pubmed:abstractText
PI31 is a previously described inhibitor of 20S proteasomes. Using recombinant PI31 we have analyzed its effect on proteasomal hydrolyzing activity of short fluorogenic substrates and of a synthetic 40-mer polypeptide. In addition, we investigated its influence on the activation of 20S proteasome by the proteasome activator PA28. PI31 inhibits polypeptide degradation already at concentrations which only partially inhibit fluorogenic substrate turnover and immunosubunits do not influence the PI31 binding affinity. Furthermore our data demonstrate that PI31 is a potent competitor of PA28-mediated activation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Autoantigens, http://linkedlifedata.com/resource/pubmed/chemical/Cysteine Endopeptidases, http://linkedlifedata.com/resource/pubmed/chemical/Cysteine Proteinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Glutathione Transferase, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma, http://linkedlifedata.com/resource/pubmed/chemical/Ki antigen, http://linkedlifedata.com/resource/pubmed/chemical/Multienzyme Complexes, http://linkedlifedata.com/resource/pubmed/chemical/Muscle Proteins, http://linkedlifedata.com/resource/pubmed/chemical/PSME1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Proteasome Endopeptidase Complex, http://linkedlifedata.com/resource/pubmed/chemical/Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0014-5793
pubmed:author
pubmed:issnType
Print
pubmed:day
3
pubmed:volume
457
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
333-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:10471803-Amino Acid Sequence, pubmed-meshheading:10471803-Animals, pubmed-meshheading:10471803-Autoantigens, pubmed-meshheading:10471803-Binding, Competitive, pubmed-meshheading:10471803-Cell Line, pubmed-meshheading:10471803-Cloning, Molecular, pubmed-meshheading:10471803-Cysteine Endopeptidases, pubmed-meshheading:10471803-Cysteine Proteinase Inhibitors, pubmed-meshheading:10471803-Enzyme Activation, pubmed-meshheading:10471803-Glutathione Transferase, pubmed-meshheading:10471803-Humans, pubmed-meshheading:10471803-Interferon-gamma, pubmed-meshheading:10471803-Mice, pubmed-meshheading:10471803-Molecular Sequence Data, pubmed-meshheading:10471803-Multienzyme Complexes, pubmed-meshheading:10471803-Muscle Proteins, pubmed-meshheading:10471803-Proteasome Endopeptidase Complex, pubmed-meshheading:10471803-Proteins, pubmed-meshheading:10471803-Recombinant Fusion Proteins, pubmed-meshheading:10471803-Sequence Homology, Amino Acid
pubmed:year
1999
pubmed:articleTitle
The proteasome inhibitor PI31 competes with PA28 for binding to 20S proteasomes.
pubmed:affiliation
Institute of Biochemistry/Charité, Monbijou Strasse 2, D-10117, Berlin, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't